Genetic polymorphisms in human GSTs have been linked with oxidative DNA damage and subsequently an increased risk of cancer susceptibility [19], while schistosomal GSTs have been considered as potential components in vaccines [20] and as targets for schistosomiasis drug therapy [21]. Here, HPGDS is linked to cancer.